A NEW breast cancer therapy shown to significantly reduce the risk of cancer recurrence and improve disease-free survival in women is now approved for use in Thailand.[1,2,3] ...

If you’ve been on the internet recently, you’ve likely encountered Bryan Johnson’s meticulously optimized, data-driven quest ...

Low-fat diets are problematic, says world-renowned internist and regenerative physician Michael Aziz, MD, author of the ...

Individual patient data from neoadjuvant randomized breast cancer clinical trials with available data on pathologic complete ...

Enhertu (fam-trastuzumab deruxtecan-nxki) has received FDA approval for HR-positive, HER2-low, HER2-ultralow metastatic breast cancer.

Alt had his hormone levels checked and was put on human growth hormone as well as testosterone. Having tried so many different things across the years, he wasn't too optimistic. Three weeks later ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its ...

We spoke with registered dietitians to break down the benefits, potential risks and what you should know before adding ...

Robert F. Kennedy Jr. appears poised to be confirmed in the coming days as the nation’s top health official. Kennedy has many ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...